Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche
Go back to Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche| PACIFIC BIO CA (NASDAQ: PACB) | Delayed: 1.31 -0.01 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.32 | 52 Week High | $14.00 | |||
| Open | $1.30 | 52 Week Low | $6.61 | |||
| Day High | $1.37 | P/E | N/A | |||
| Day Low | $1.30 | EPS | $-1.26 | |||
| Volume | 3,964,970 | |||||
